InoLife Technologies, Inc.
(Other OTC/NBB : INOL)

( )
INOL PreMarket: $ () as of AM
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards



Technology Services » Internet Software Or Services

Company Profile

InoLife Technologies, Inc. operates as a development stage service based healthcare product marketing company. The company currently market: a DNA testing for Plavix; pre disposition screening for certain genetic diseases, and ancestry and paternity tests. The principal users of products include healthcare providers including physicians, hospitals, and outpatient facilities, in addition to individuals with a direct need for the solutions. The company's products will be sold directly to consumers through e-commerce, direct sales, pharmacies, retailers, distributors and healthcare providers. InoLife Technologies was founded on November 12, 1998 and is headquartered in New York, NY.